MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics
Noninvasive Hemodynamics for MultiPoint(TM) Pacing Programming in Cardiac Resynchronization Therapy Patients
1 other identifier
interventional
40
3 countries
4
Brief Summary
The purpose of this study is to evaluate noninvasive hemodynamics with MultiPoint™ Pacing (MPP) and biventricular (BiV) pacing under various vector combinations and paced delays in patients receiving cardiac resynchronization therapy (CRT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Mar 2014
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2014
CompletedFirst Posted
Study publicly available on registry
February 17, 2014
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFebruary 4, 2019
January 1, 2019
2.2 years
February 14, 2014
January 31, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Systolic blood pressure changes in hemodynamics during BiV pacing and MPP
up to 6-months
Secondary Outcomes (1)
echocardiographic changes to MPP programming guided by noninvasive hemodynamic measurements
6 months
Study Arms (1)
MultiPoint Pacing
EXPERIMENTALCRT with MultiPoint Pacing
Interventions
Eligibility Criteria
You may qualify if:
- Be scheduled to undergo de novo implant of a St. Jude Medical CRT-D system
- Be in NYHA II or III functional class with approved standard indication by ESC/EHRA Guidelines
- Have the ability to provide informed consent for study participation and be willing and able to comply with the Clinical Investigation Plan (CIP) described evaluations and follow-up schedule
You may not qualify if:
- Have persistent or permanent atrial fibrillation
- Have a recent myocardial infarction within 40 days prior to enrollment
- Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures in the following 12 months
- Have had a recent Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) within 3 months prior to enrollment
- Have had intravenous inotropic support in the last 30 days
- Be scheduled or considered for heart transplantation over the next 12 months
- Be less than 18 years of age
- Be pregnant or plan to become pregnant over the next 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Medizinische Universität Graz
Graz, Austria
CHU Rennes
Rennes, France
Niguarda Hospital
Milan, Italy
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christophe Leclercq, MD, PhD
University Hospital Rennes, Rennes, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2014
First Posted
February 17, 2014
Study Start
March 1, 2014
Primary Completion
May 1, 2016
Study Completion
June 1, 2016
Last Updated
February 4, 2019
Record last verified: 2019-01